Did Lilly Overcome US Price Pressures In Last Quarter? Investors Await Answer

 
• By Joseph Haas

With business heavily dependent on sales revenue from Medicare Part D and other US government programs, Lilly will be expected to narrow the gap between US prescription and sales growth.

Medicare Part D text on calculator with prescription pills in bottle on American money
Lilly is more reliant on sales from Medicare Part D than its peers

More from Earnings

More from Business